World Journal of Stem Cells,
Journal Year:
2025,
Volume and Issue:
17(2)
Published: Feb. 24, 2025
The
potential
of
induced
pluripotent
stem
cells
(iPSCs)
for
modeling
and
treating
metabolic
associated
fatty
liver
disease
(MAFLD)
steatohepatitis
(MASH)
is
emerging.
MAFLD
a
growing
global
health
concern,
currently
with
limited
treatment
options.
While
primary
mesenchymal
hold
promise,
iPSCs
offer
versatile
alternative
due
to
their
ability
differentiate
into
various
cell
types,
including
iPSC-derived
cells.
However,
challenges
remain,
optimizing
differentiation
protocols,
ensuring
safety,
addressing
tumorigenicity
risks.
In
addition,
the
possibility
generate
complex
cellular
models,
three-dimensional
organoid
which
are
closer
representations
human
than
animal
models.
Those
models
would
also
be
valuable
drug
discovery
personalized
medicine
approaches.
Overall,
derivatives
new
perspectives
advancing
MAFLD/MASH
research
developing
novel
therapeutic
strategies.
Further
needed
overcome
current
limitations
translate
this
effective
clinical
applications.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 24, 2023
Spinal
cord
injury
(SCI)
has
considerable
impact
on
patient
physical,
mental,
and
financial
health.
Secondary
SCI
is
associated
with
inflammation,
vascular
destruction,
subsequent
permanent
damage
to
the
nervous
system.
Mesenchymal
stem
cells
(MSCs)
have
anti-inflammatory
properties,
promoting
regeneration
release
neuro-nutrients,
are
a
promising
strategy
for
treatment
of
SCI.
Preclinical
studies
shown
that
MSCs
promote
sensory
motor
function
recovery
in
rats.
In
clinical
trials,
been
reported
improve
American
Injury
Association
(ASIA)
scores.
However,
effectiveness
treating
patients
remains
controversial.
tumorigenesis
ensuring
survival
hostile
environment
challenging.
this
article
we
examine
evidence
pathophysiological
changes
occurring
after
We
then
review
underlying
mechanisms
summarize
potential
application
practice.
Finally,
highlight
challenges
surrounding
use
discuss
future
applications.
Periodontology 2000,
Journal Year:
2024,
Volume and Issue:
94(1), P. 257 - 414
Published: Feb. 1, 2024
Abstract
Exosomes
are
the
smallest
subset
of
extracellular
signaling
vesicles
secreted
by
most
cells
with
ability
to
communicate
other
tissues
and
cell
types
over
long
distances.
Their
use
in
regenerative
medicine
has
gained
tremendous
momentum
recently
due
their
be
utilized
as
therapeutic
options
for
a
wide
array
diseases/conditions.
Over
5000
publications
currently
being
published
yearly
on
this
topic,
number
is
only
expected
dramatically
increase
novel
strategies
continue
developed.
Today
exosomes
have
been
applied
numerous
contexts
including
neurodegenerative
disorders
(Alzheimer's
disease,
central
nervous
system,
depression,
multiple
sclerosis,
Parkinson's
post‐traumatic
stress
disorders,
traumatic
brain
injury,
peripheral
nerve
injury),
damaged
organs
(heart,
kidney,
liver,
stroke,
myocardial
infarctions,
ovaries),
degenerative
processes
(atherosclerosis,
diabetes,
hematology
musculoskeletal
degeneration,
osteoradionecrosis,
respiratory
disease),
infectious
diseases
(COVID‐19,
hepatitis),
procedures
(antiaging,
bone
regeneration,
cartilage/joint
osteoarthritis,
cutaneous
wounds,
dental
dermatology/skin
erectile
dysfunction,
hair
regrowth,
intervertebral
disc
repair,
spinal
cord
vascular
regeneration),
cancer
therapy
(breast,
colorectal,
gastric
osteosarcomas),
immune
function
(allergy,
autoimmune
regulation,
inflammatory
diseases,
lupus,
rheumatoid
arthritis).
This
scoping
review
first
its
kind
aimed
at
summarizing
extensive
potential
broad
range
disorders.
International Journal of Nanomedicine,
Journal Year:
2022,
Volume and Issue:
Volume 17, P. 3893 - 3911
Published: Sept. 1, 2022
Abstract:
The
recent
rapid
development
in
the
field
of
extracellular
vesicles
(EVs)
based
nanotechnology
has
provided
unprecedented
opportunities
for
nanomedicine
platforms.
As
natural
nanocarriers,
EVs
such
as
exosomes,
exosome-like
nanoparticles
and
outer
membrane
(OMVs),
have
unique
structure/composition/morphology
characteristics,
show
excellent
physical
chemical/biochemical
properties,
making
them
a
new
generation
theranostic
nanomedicine.
Here,
we
reviewed
characteristics
from
perspective
their
formation
biological
function
inflammatory
bowel
disease
(IBD).
Moreover,
can
crucially
participate
interaction
communication
intestinal
epithelial
cells
(IECs)-immune
cells-gut
microbiota
to
regulate
immune
response,
inflammation
homeostasis.
Interestingly,
on
current
representative
examples
exosomes
IBD
treatment,
it
is
shown
that
plant,
milk,
cells-derived
exert
therapeutic
effect
through
components,
proteins,
nucleic
acid,
lipids.
several
drug
loading
methods
target
modification
are
used
improve
capability.
We
also
discussed
application
treatment
IBD.
In
this
review,
aim
better
more
clearly
clarify
underlying
mechanisms
pathogenesis
IBD,
provide
directions
mediated
treatment.
Keywords:
vesicles,
exosome,
nanoparticles,
disease,
Extracellular Vesicle,
Journal Year:
2024,
Volume and Issue:
3, P. 100034 - 100034
Published: March 2, 2024
Mesenchymal
stem
cells
(MSCs)
have
been
studied
for
decades
as
candidates
cellular
therapy,
and
their
secretome,
including
secreted
extracellular
vesicles
(EVs),
has
identified
to
contribute
significantly
regenerative
reparative
functions.
Emerging
evidence
suggested
that
MSC-EVs
alone,
could
be
used
therapeutics
emulate
the
biological
function
of
MSCs.
However,
just
with
MSCs,
shown
vary
in
composition,
depending
on
tissue
source
MSCs
well
protocols
employed
culturing
obtaining
EVs.
Therefore,
importance
careful
choice
cell
sources
culture
environments
is
receiving
increasing
attention.
Many
factors
therapeutic
potential
MSC-EVs,
tissue,
isolation
technique,
conditions.
This
review
illustrates
molecular
landscape
EVs
derived
from
different
types
MSC
along
strategies.
A
thorough
analysis
publicly
available
omic
datasets
was
performed
advance
precision
understanding
unique
source-dependent
characteristics.
The
tissue-specific
protein
miRNA-driven
Reactome
ontology
reveal
distinct
patterns
top
pathways
across
adipose,
bone
marrow,
umbilical
MSC-EVs.
Moreover,
a
meta-analysis
assisted
by
an
AI
technique
analyze
published
literature,
providing
insights
into
translation
based
tissues.
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Spinal
cord
injury
(SCI)
can
cause
irreversible
trauma
to
nervous
tissue,
leading
permanent
damage
the
patient's
motor
and
sensory
functions.
Extracellular
vesicles
derived
from
mesenchymal
stem
cells
(MSC-EVs)
simulate
most
of
functions
MSCs
are
considered
an
ideal
treatment
option
for
SCI.
However,
potential
mechanism
MSC-EVs
SCI
still
needs
be
explored.
We
cultured
neurons
in
vitro
investigate
effect
miR-124
on
p62-Keap1-Nrf2
pathway.
Besides,
containing
were
injected
into
a
rat
spinal
model
observe
their
neural
repair
effect.
The
accumulation
p62
reversed
by
miR-124,
which
promotes
autophagy
alleviates
oxidative
stress,
thereby
exerting
neuroprotective
effects.
Rats
who
received
injection
overexpressing
after
surgery
showed
higher
BBB
scores,
lower
levels
cell
apoptosis,
better
tissue
morphology.
Our
results
indicated
that
stabilize
loop,
promoting
alleviating
stress
exert
research
proposes
novel
target
treating
Neural Regeneration Research,
Journal Year:
2022,
Volume and Issue:
18(5), P. 1067 - 1067
Published: Oct. 27, 2022
Although
many
therapeutic
interventions
have
shown
promise
in
treating
spinal
cord
injury,
focusing
on
a
single
aspect
of
repair
cannot
achieve
successful
and
functional
regeneration
patients
following
injury
.
In
this
study,
we
applied
combinatorial
approach
for
involving
neuroprotection
rehabilitation,
exploiting
cell
transplantation
sensorimotor
training
to
promote
nerve
recovery.
Here,
used
mouse
model
thoracic
contusive
investigate
whether
the
combination
bone
marrow
mesenchymal
stem
exercise
has
synergistic
effect
restoration.
Locomotor
function
was
evaluated
by
Basso
Mouse
Scale,
horizontal
ladder
test,
footprint
analysis.
Magnetic
resonance
imaging,
histological
examination,
transmission
electron
microscopy
observation,
immunofluorescence
staining,
western
blotting
were
performed
8
weeks
after
further
explore
potential
mechanism
behind
effect.
vivo,
showed
better
motor
than
treatments.
Further
investigations
revealed
that
markedly
reduced
fibrotic
scar
tissue,
protected
neurons,
promoted
axon
myelin
protection.
Additionally,
effects
recovery
occurred
via
PI3K/AKT/mTOR
pathway.
vitro,
experimental
evidence
from
PC12
line
primary
cortical
neuron
culture
also
demonstrated
blocking
pathway
would
aggravate
neuronal
damage.
Thus,
combined
with
can
effectively
restore
activating
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2023,
Volume and Issue:
11
Published: March 13, 2023
Spinal
cord
injury
(SCI)
is
a
serious
and
disabling
disease
with
high
mortality
rate.
It
often
leads
to
complete
or
partial
sensory
motor
dysfunction
accompanied
by
series
of
secondary
outcomes,
such
as
pressure
sores,
pulmonary
infections,
deep
vein
thrombosis
in
the
lower
extremities,
urinary
tract
autonomic
dysfunction.
Currently,
main
treatments
for
SCI
include
surgical
decompression,
drug
therapy,
postoperative
rehabilitation.
Studies
have
shown
that
cell
therapy
plays
beneficial
role
treatment
SCI.
Nonetheless,
there
controversy
regarding
therapeutic
effect
transplantation
models.
Meanwhile
exosomes,
new
medium
regenerative
medicine,
possess
advantages
small
size,
low
immunogenicity,
ability
cross
blood-spinal
barrier.
Certain
studies
stem
cell-derived
exosomes
anti-inflammatory
effects
can
play
an
irreplaceable
In
this
case,
it
difficult
single
method
effective
repair
neural
tissue
after
The
combination
biomaterial
scaffolds
better
transfer
fix
site
improve
their
survival
This
paper
first
reviews
current
research
status
respectively,
then
describes
application
combined
SCI,
well
challenges
prospects.